Cancer cells with high expression of CD133 exert FLIP upregulation and resistance to TRAIL-induced apoptosis

BioFactors

Volumn 34, Issue 3, 2008, Pages 231-235

  Zobalova, Renata ^a,b   Stantic, Marina ^a   Prokopova, Katerina ^b   Dong, Lan Feng ^a   Neuzil, Jiri ^a,b  

^a GRIFFITH UNIVERSITY   (Australia)

^b INSTITUTE OF BIOTECHNOLOGY   (Czech Republic)

Author keywords

Apoptosis; CD133; FLIP; TRAIL

Indexed keywords

CD133 ANTIGEN; FLICE INHIBITORY PROTEIN; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ANTIGEN EXPRESSION; APOPTOSIS; CANCER CELL; CONFERENCE PAPER; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

EID: 70249107161     PISSN: 09516433     EISSN: None     Source Type: Journal    
DOI: 10.1002/biof.5520340307     Document Type: Conference Paper

References (11)

1. J.A. Aguirre-Ghiso, Models, mechanisms and clinical evidence for cancer dormancy, Nature Reviews in Cancer 7 (2007), 834-846.
2. C.W. Chan and F. Housseau, The 'kiss of death' by dendritic cells to cancer cells, Cell Death and Differentiation 15 (2008), 58-69.
3. K.A. D'Amour and F.H. Gage, Are somatic stem cells pluripotent or lineage restricted? Nature Medicine 8 (2002), 213-214.
4. C. Falschlehner, C. Emmerich, B. Gerlach and H. Walczak, TRAIL signalling: Decisions between life and death, International Journal of Biochemistry and Cell Biology 39 (2007), 1462-1475.
5. R. Handgretinger, P.R. Gordon, T. Leimig, X. Chen, H.J. Buhring, D. Niethammer and S. Kuci, Biology and plasticity of CD133+ hematopoietic stem cells, Annals of the New York Academy of Sciences 996 (2003), 141-151.
6. G. Liu, X. Yuan, Z. Zeng, P. Tunici, H. Ng, I.R. Abdulkadir, L. Lu, D. Irvin, K.L. Black and J.S. Yu, Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma, Molecular Cancer 5 (2006), 1476-1498.
7. D. Merino, N. Lalaoui, A. Morizot, P. Schneider, E. Solary and O. Micheau, Differential inhibition of TRAIL-mediated DR5-DISC formation by decoy receptors 1 and 2, Molecular Cell Biology 26 (2006), 7046-7055.
8. K. Polyak and W.C. Hahn, Roots and stems: stem cells in cancer, Nature Medicine 11 (2006), 296-298.
9. D. Siegmund, P. Hadwiger, K. Pfizenmaier, H.P. Vornlocher and H. Wajant, Selective inhibition of FLICE-like inhibitory protein expression with small interfering RNA oligonucleotides is sufficient to sensitize tumour cells for TRAIL-induced apoptosis, Molecular Medicine 8 (2002), 725-732.
10. S.K. Singh, C. Hawkins, I.D. Clarke, J.A. Squire, J. Bayani, T. Hide, R.M. Henkelman, M.D. Cusimano and P.B. Dirks, Identification of human brain tumour initiating cells, Nature 432 (2004), 396-401.
11. X. Zhang, T. Jin, H. Yang, W. DeWolf, R. Khosravi-Far and F. Olumi, Persistent c FLIPL expression is necessary and sufficient to maintain resistance to tumour necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in prostate cancer, Cancer Research 64 (2004), 7086-7091.